Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Pontiroli

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Is insulin the only treatment for obese NIDDM patients poorly controlled by oral hypoglycemic agents?A E Pontiroli
Aging (Milan, Italy)|January 1, 1989
Long-term training in gerontology and geriatricsA E Pontiroli
Acta Diabetologica|February 6, 2002
EMEA extends indications for metformin. A decision that relies on evidence-based medicineA E Pontiroli
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 18, 2012
Bariatric surgery for obese type 2 diabetes: do we have enough information?A E Pontiroli
Acta Diabetologica|January 26, 2005
Type 2 diabetes mellitus is becoming the most common type of diabetes in school childrenA E Pontiroli
Journal of Endocrinological Investigation|May 1, 1995
About the effects of glucagon on growth hormone releaseA E Pontiroli
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 1990
Intranasal administration of peptide hormones: factors affecting transmucosal absorptionA E Pontiroli, G Pozza
Acta Diabetologica|December 5, 1998
Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidaemiaA E Pontiroli, L Galli
British Medical Journal (Clinical Research Ed.)|February 18, 1984
Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristicsA E Pontiroli, L Falsetti
Acta Diabetologica|July 18, 2002
Additive effect of overweight and type 2 diabetes in the appearance of coronary heart disease but not of stroke: a cross-sectional studyA E Pontiroli, R Camisasca
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Endocrinology and Metabolism|June 17, 1998
Is insulin the only treatment for obese NIDDM patients poorly controlled by oral hypoglycemic agents?A E Pontiroli
Aging (Milan, Italy)|January 1, 1989
Long-term training in gerontology and geriatricsA E Pontiroli
Acta Diabetologica|February 6, 2002
EMEA extends indications for metformin. A decision that relies on evidence-based medicineA E Pontiroli
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 18, 2012
Bariatric surgery for obese type 2 diabetes: do we have enough information?A E Pontiroli
Acta Diabetologica|January 26, 2005
Type 2 diabetes mellitus is becoming the most common type of diabetes in school childrenA E Pontiroli
Journal of Endocrinological Investigation|May 1, 1995
About the effects of glucagon on growth hormone releaseA E Pontiroli
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 1990
Intranasal administration of peptide hormones: factors affecting transmucosal absorptionA E Pontiroli, G Pozza
Acta Diabetologica|December 5, 1998
Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidaemiaA E Pontiroli, L Galli
British Medical Journal (Clinical Research Ed.)|February 18, 1984
Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristicsA E Pontiroli, L Falsetti
Acta Diabetologica|July 18, 2002
Additive effect of overweight and type 2 diabetes in the appearance of coronary heart disease but not of stroke: a cross-sectional studyA E Pontiroli, R Camisasca
Pageof 22